FDA Approves Mucinex 12HR Cold & Fever Multi-Symptom (dextromethorphan, guaifenesin and naproxen) for Cold & Flu Symptoms

Дата публикации: 05-08-2026 01:08:45

NUTLEY, N.J., AUGUST 5, 2026 – Reckitt announced today a milestone for the cold and flu category and the company: Mucinex® 12HR Cold & Fever Multi-Symptom is the first U.S. Food and Drug Administration (FDA)-approved over-the-counter...

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FDA Approves Tylenol with Naproxen (acetaminophen and naproxen sodium) for Over-the-Counter Treatment of Pain	0	14.01	24-07-2026
2	FDA Approves mFLUSIVA (influenza vaccine, mRNA) for the Prevention of Seasonal Influenza	0	10.86	05-08-2026
3	FDA approves first OTC combo of Tylenol and Naproxen for 'non-opioid' pain relief	0	10.33	29-07-2026
4	FDA approves first OTC combo of Tylenol and Naproxen for 'non-opioid' pain relief	0	10.33	29-07-2026
5	FDA approves first OTC combo of Tylenol and Naproxen for 'non-opioid' pain relief	0	10.33	29-07-2026
6	FDA approves first OTC combo of Tylenol and Naproxen for 'non-opioid' pain relief	0	10.33	01-08-2026
7	FDA approves first mRNA flu vaccine	0	5.78	06-08-2026
8	FDA panel backs first-of-its-kind flu vaccine using mRNA technology	0	7	18-06-2026
9	Glenmark Receives U.S. FDA Approval to Expand the Use of Ryaltris Nasal Spray for Children Aged 6 to Less Than 12 Years	0	13.57	21-07-2026
10	FDA panel backs first-of-its-kind flu vaccine using mRNA technology	5	7	18-06-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 14.32. Источник: www.drugs.com.